| Literature DB >> 19318313 |
Herbert Tilg1, Alexander R Moschen, Arthur Kaser.
Abstract
Type I interferons (IFNs) are the first line of defence after various infections, and, as immunomodulatory cytokines, bridge innate and adaptive immunity. IL-17, mainly secreted by specific T cells, has recently been identified regulating neutrophil-mediated inflammation, and has been implicated in the pathogenesis of many acute and chronic inflammatory disorders. This cytokine is considered of critical importance for an effective anti-bacterial and anti-fungal immune response as needed subsequent to many viral infections. Recent studies have demonstrated that type I IFNs potently suppress IL-17 expression and Th17 differentiation in vitro and in vivo. Therefore, suppression of IL-17, as well as many other well-defined interactions of type I IFNs with the cytokine cascade, may contribute to virus-induced immunosuppression making the host vulnerable to bacterial and fungal attacks.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19318313 DOI: 10.1684/ecn.2009.0141
Source DB: PubMed Journal: Eur Cytokine Netw ISSN: 1148-5493 Impact factor: 2.737